Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Potencies

FIGURE 1-3 Relative potency and maximal efficacy of two drugs. Drug A is more potent, and drug B has a greater maximal efficacy. [Pg.9]


The second application of the CFTI protocol is the evaluation of the free energy differences between four states of the linear form of the opioid peptide DPDPE in solution. Our primary result is the determination of the free energy differences between the representative stable structures j3c and Pe and the cyclic-like conformer Cyc of linear DPDPE in aqueous solution. These free energy differences, 4.0 kcal/mol between pc and Cyc, and 6.3 kcal/mol between pE and Cyc, reflect the cost of pre-organizing the linear peptide into a conformation conducive for disulfide bond formation. Such a conformational change is a pre-requisite for the chemical reaction of S-S bond formation to proceed. The predicted low population of the cyclic-like structure, which is presumably the biologically active conformer, agrees qualitatively with observed lower potency and different receptor specificity of the linear form relative to the cyclic peptide. [Pg.173]

Lead structure According to Valler and Green s definition a lead structure is a representative of a compound series with sufficient potential (as measured by potency, selectivity, pharmacokinetics, physicochemical properties, absence of toxicity and novelty) to progress to a full drug development program [12]. [Pg.599]

The term virtual screening or in silica screening is defined as the selection of compounds by evaluating their desirability in a computational model [17]. The desirability comprises high potency, selectivity, appropriate pharmacokinetic properties, and favorable toxicology. [Pg.603]

The purpose of this eornpuLer project is Lo examine several polynuclear aromatic hydrocarbons and to relate their electron density patterns to their carcinogenic activity. If nucleophilic binding to DN.A is a significant step in blocking the normal transcription process of DN.A, electron density in the hydrocarbon should be positively correlated to its carcinogenic potency. To begin with, we shall rely on clinical evidence that benzene, naphthalene, and phenanthrene... [Pg.291]

Enediynes hold substantial promise as anti cancer drugs because of their potency and selectivity Not only do they inhibit cell growth they have a greater tendency to kill cancer cells than they do normal cells The mechanism by which enediynes act involves novel chemistry unique to the C C—C=C—C C unit which leads to a species that cleaves DNA and halts tumor growth... [Pg.368]

Sweetness evaluation Sweetness potency Sweet n Low Sweet potato Sweet potatoes Sweetzyme Swelling Swimmingpool Swimming p o ols... [Pg.955]

This reversed-phase chromatography method was successfully used in a production-scale system to purify recombinant insulin. The insulin purified by reversed-phase chromatography has a biological potency equal to that obtained from a conventional system employing ion-exchange and size-exclusion chromatographies (14). The reversed-phase separation was, however, followed by a size-exclusion step to remove the acetonitrile eluent from the final product (12,14). [Pg.55]

Methylated Glucocorticoids. The preparation of 2a-methyl-9a- uorocortisol has been reported (76). This compound shows enhanced glucocorticoid activity and greatiy enhanced mineralocorticoid activity, so much that it surpasses aldosterone (19) ia sodium-retaining and potassium-excreting potency. Attention was then turned to the preparation of 6-methylated corticoids... [Pg.101]

Another series of antiinflammatory carboxyhc acids that ate derived from cortienic acid (107), a minor adrenal metabohte, has been described (104,105). Esterification of both the 17a-hydroxyl group and the carboxyhc acid of (107) were requited to develop a compound of high topical potency with low systemic activity. Peak activity was generally associated with a 17a-propionoxy group and a 17P- uoromethoxy carbonyl (eg, (108)), or 17P-methoxycarbonyl residue. [Pg.106]

As a class of compounds, the two main toxicity concerns for nitriles are acute lethality and osteolathyrsm. A comprehensive review of the toxicity of nitriles, including detailed discussion of biochemical mechanisms of toxicity and stmcture-activity relationships, is available (12). Nitriles vary broadly in their abiUty to cause acute lethaUty and subde differences in stmcture can greatly affect toxic potency. The biochemical basis of their acute toxicity is related to their metaboHsm in the body. Following exposure and absorption, nitriles are metabolized by cytochrome p450 enzymes in the Hver. The metaboHsm involves initial hydrogen abstraction resulting in the formation of a carbon radical, followed by hydroxylation of the carbon radical. MetaboHsm at the carbon atom adjacent (alpha) to the cyano group would yield a cyanohydrin metaboHte, which decomposes readily in the body to produce cyanide. Hydroxylation at other carbon positions in the nitrile does not result in cyanide release. [Pg.218]

Determination of the potency of Factor VIII is also difficult. This is normally measured by the abiUty of the sample to correct the clotting time of plasma deficient in Factor VIII. A number of methods and practices have evolved for this purpose (231), but these give very different results, particularly when activation of products may also occur (232). International standards have been used, but further standardization of the analytical method and harmonization of working standards is underway (233,234) under the auspices of the ISTH and the EC. [Pg.536]

Cascara sagrada is used as a cathartic. It is most useful when prepared as a fluid extract, and tends to be a mild laxative causing Htfle discomfort. However, on prolonged use it may result in characteristic melanotic pigmentation of the rectal mucosa. The bitter taste can be lessened, owing to neutralization of the acid constituents, if the ground substance is moistened and mixed with magnesium or calcium hydroxide. This treatment may lessen the potency of the preparation. [Pg.201]

This correlates narcotic potency, a gas s solubiUty in nerve tissue Hpids which can be approximated by its solubiUty in light oils such as oHve oil. [Pg.17]

The narcotic potency and solubiUty in oHve oil of several metabohcaHy inert gases are Hsted in Table 10. The narcotic potency, ED q, is expressed as the partial pressure of the gas in breathing mixtures requited to produce a certain degree of anesthesia in 50% of the test animals. The solubiUties are expressed as Bunsen coefficients, the volume of atmospheric pressure gas dissolved by an equal volume of Hquid. The Hpid solubiHty of xenon is about the same as that of nitrous oxide, a commonly used light anesthetic, and its narcotic potency is also about the same. As an anesthetic, xenon has the virtues of reasonable potency, nonflammability, chemical inertness, and easy elimination by the body, but its scarcity and great cost preclude its wide use for this purpose (see Anesthetics). [Pg.17]

Table 10. Narcotic Potency and Solubility in Olive Oil of Some Metabolically Inert Gases ... Table 10. Narcotic Potency and Solubility in Olive Oil of Some Metabolically Inert Gases ...
ED q, narcotic potency, is expressed as the partial pressure of a gas in breathing mixtures requited to produce a certain degree of anesthesia in 50% of the test animals. [Pg.17]

Astemi2ole (10) has further been modified into a series of 4-phenylcyclohexylamine compounds, resulting in the synthesis of cabastine, for example. Cabastine is a highly active compound and its geometric isomers are also active, demonstrating the stereoselectivity of histamine receptors toward chiral ligands. The > S, 4 R-levo antipode of cabastine was the most active, and therefore this isomer, levocabastine (13), has been chosen for further development. Because of high potency, levocabastine has been developed for topical appHcation such as eye drops and nasal spray. [Pg.139]

P-Endorphin. A peptide corresponding to the 31 C-terminal amino acids of P-LPH was first discovered in camel pituitary tissue (10). This substance is P-endorphin, which exerts a potent analgesic effect by binding to cell surface receptors in the central nervous system. The sequence of P-endorphin is well conserved across species for the first 25 N-terminal amino acids. Opiates derived from plant sources, eg, heroin, morphine, opium, etc, exert their actions by interacting with the P-endorphin receptor. On a molar basis, this peptide has approximately five times the potency of morphine. Both P-endorphin and ACTH ate cosecreted from the pituitary gland. Whereas the physiologic importance of P-endorphin release into the systemic circulation is not certain, this molecule clearly has been shown to be an important neurotransmitter within the central nervous system. Endorphin has been invaluable as a research tool, but has not been clinically useful due to the avadabihty of plant-derived opiates. [Pg.175]


See other pages where Potencies is mentioned: [Pg.59]    [Pg.171]    [Pg.602]    [Pg.616]    [Pg.657]    [Pg.683]    [Pg.683]    [Pg.709]    [Pg.711]    [Pg.711]    [Pg.660]    [Pg.806]    [Pg.9]    [Pg.94]    [Pg.94]    [Pg.104]    [Pg.168]    [Pg.452]    [Pg.480]    [Pg.532]    [Pg.536]    [Pg.183]    [Pg.17]    [Pg.39]    [Pg.140]    [Pg.140]    [Pg.149]    [Pg.176]    [Pg.176]    [Pg.176]    [Pg.176]   
See also in sourсe #XX -- [ Pg.114 ]

See also in sourсe #XX -- [ Pg.233 , Pg.236 , Pg.237 ]

See also in sourсe #XX -- [ Pg.184 ]

See also in sourсe #XX -- [ Pg.419 ]

See also in sourсe #XX -- [ Pg.17 ]

See also in sourсe #XX -- [ Pg.4 ]

See also in sourсe #XX -- [ Pg.404 ]

See also in sourсe #XX -- [ Pg.5 , Pg.16 ]

See also in sourсe #XX -- [ Pg.54 , Pg.60 , Pg.61 ]

See also in sourсe #XX -- [ Pg.7 , Pg.11 , Pg.30 , Pg.47 ]

See also in sourсe #XX -- [ Pg.290 ]

See also in sourсe #XX -- [ Pg.26 , Pg.42 , Pg.79 , Pg.159 , Pg.166 , Pg.167 , Pg.232 , Pg.241 , Pg.244 ]

See also in sourсe #XX -- [ Pg.32 ]

See also in sourсe #XX -- [ Pg.77 ]

See also in sourсe #XX -- [ Pg.353 , Pg.371 , Pg.375 ]

See also in sourсe #XX -- [ Pg.9 , Pg.9 ]

See also in sourсe #XX -- [ Pg.9 ]

See also in sourсe #XX -- [ Pg.122 , Pg.123 ]

See also in sourсe #XX -- [ Pg.70 ]

See also in sourсe #XX -- [ Pg.60 ]

See also in sourсe #XX -- [ Pg.364 ]

See also in sourсe #XX -- [ Pg.139 , Pg.144 , Pg.145 ]

See also in sourсe #XX -- [ Pg.33 ]

See also in sourсe #XX -- [ Pg.337 ]

See also in sourсe #XX -- [ Pg.94 ]

See also in sourсe #XX -- [ Pg.83 , Pg.84 ]

See also in sourсe #XX -- [ Pg.423 ]

See also in sourсe #XX -- [ Pg.156 ]

See also in sourсe #XX -- [ Pg.218 ]

See also in sourсe #XX -- [ Pg.89 ]

See also in sourсe #XX -- [ Pg.124 , Pg.138 , Pg.154 , Pg.155 , Pg.159 , Pg.179 , Pg.194 , Pg.206 , Pg.207 , Pg.211 , Pg.212 , Pg.287 , Pg.395 , Pg.396 , Pg.405 , Pg.412 , Pg.432 , Pg.437 , Pg.456 , Pg.692 ]

See also in sourсe #XX -- [ Pg.37 ]

See also in sourсe #XX -- [ Pg.50 , Pg.62 , Pg.87 ]

See also in sourсe #XX -- [ Pg.56 ]

See also in sourсe #XX -- [ Pg.22 , Pg.77 ]

See also in sourсe #XX -- [ Pg.105 ]

See also in sourсe #XX -- [ Pg.149 , Pg.151 ]

See also in sourсe #XX -- [ Pg.482 , Pg.483 , Pg.483 ]

See also in sourсe #XX -- [ Pg.59 , Pg.63 , Pg.64 ]

See also in sourсe #XX -- [ Pg.25 ]

See also in sourсe #XX -- [ Pg.205 ]




SEARCH



0-Adrenergic agonist potency

0-Adrenergic potency

0-Adrenoreceptor potency

02-Adrenoreceptors potency

6-Adrenergic blocking potency

Acceptance criteria potency

Accuracy potency

Acetylcholinesterase reactivators reactivation potency

Acidic amino acids, relative excitatory potencies

Action of a homeopathic potency

Affinity, efficacy and potency

Agonist antagonist potency

Analgesic potencies

Analgesic potencies of opioid analogues

Anesthesia/anesthetics potency, measurement

Anesthetics blocking potency

Antagonist potencies

Antagonist potencies, oxytocin

Antagonist potencies, oxytocin analogs

Anti-AChE potency

Antibiotic potency

Antibiotic potency analogue

Antibodies increasing potency

Antidepressant drugs relative potency

Antiemetic agents potency

Antioxidant potency

Antipsychotic drugs potency

Apomorphine potency

Betamethasone potency

Bioactivity potency

Bioassays product potency determined

Bioisosteric Groupings to Improve Target Potency

Biotherapeutics potency

Blockers potency, cardiac

Boronic acid-Nucleophile Complex Formed in the Enzyme Active Site as a way to Improve Potency and Selectivity

Bound carcinogenic potency

Broussonetia kazinoki sexual potency

Cannabis potency increases

Carcinogen Potency Factor

Carcinogenic Potency Database

Carcinogenic Potency Database CPDB)

Carcinogenic potency

Carcinogens potency

Cardiac blocking potency

Catalytic potency

Chemical potency

Chemopreventive potency

Chlorpyrifos inhibitory potency

Chlorpyrifos relative inhibitory potency

Ciprofloxacin comparative potency

Compound potency

Consequence potency

Corticosteroids potency

Corticosteroids potency ratings

Cortisol potency

Cortisone potency

Counterscreen potency

Cyanide potency

DPDPE potency

Determination of potency

Dexamethasone potency

Dexamethasone relative potency

Dose-response curves, potency

Drug design potency

Drug design potency enhancement

Drug development inhibitory potency

Drug development potency

Drug potency

Drug potency assays

Drug products potency assessment

Ecdysteroids potency

Enantiomers potency

Estimated human potency, carcinogens

Estrogenic potencies

Estrogenicity relative estrogenic potency

Experimental potency

Exposure/Potency

Exposure/potency index

Extraction methods, effects potency

Furosemide potency

G potency

General anesthetics potency

Geometric and Electronic Potency

Glucocorticoid relative potencies

Glycemic potency

Growth Conditions and Potency

Halogenated aromatic hydrocarbon , toxic potency

Herbicides high potency

High Potency Sweeteners Aroma Interactions

High potency dosage

High potency dosage forms

High-potency BZD

High-potency pellets

In vitro potency

Inhibition potency

Inhibitory Potency Against Plant PDHc

Inhibitory potency

Inhibitory potency, differences

Insecticidal potency

Internal tamponade potency

Ionophore potency

Isoflavones estrogenic potency

Lethal toxic potencies

Linearity potency

Macromolecular therapeutics potency

Marijuana Potency (And/Or Press

Marijuana potency

Metabolites relative potency

Methylprednisolone potency

Mineralocorticoid potency

Molecular structure and potency of inhibition

Mouse intraperitoneal potency

Muscle relaxants potencies

NMR spectra of homeopathic potencies

Nalorphine clinical potency

Narcosis potency

Neonicotinoids potency

Nerve agents relative potency

Next page potency

Next page relative potency

Norfloxacin comparative potency

Obidoxime reactivation potency

Opioid analogues analgesic potencies

Opioid potency

Organophosphates inhibition potency

Oximes reactivation potency

Oxytocin analogs, potency

PAHs, Cancer Potencies, and Potency Equivalence Factors

Paraoxon potency

Pentazocine clinical potency

Pertussis potency testing

Pesticide potency

Pharmaceutical dosage form, potency

Pharmaceutical products potency determination

Pharmacodynamics potency

Phenol antioxidant potency

Physicochemical potency assay

Physiological actions potency

Potency adrenal steroids

Potency and Cannabinoid Content

Potency and Color

Potency and Efficacy

Potency and Selectivity by Introduction of Fluorine

Potency and effectiveness

Potency assay

Potency concepts

Potency definition

Potency differences

Potency factor

Potency index

Potency interactions causing loss

Potency of drugs

Potency of marijuana

Potency of nerve poisons

Potency profile

Potency quantitative structure-activity

Potency receptor structure

Potency relationships

Potency screen, plasma protein

Potency selectivity

Potency testing

Potency therapeutic

Potency uniformity

Potency, Efficacy, and Curves

Potency, additive

Potency, carcinogen risk assessment

Potency, carcinogenic defined

Potency, comparative central, peripheral

Potency, drug discovery programs

Potency, drugs cell membrane role

Potency, drugs factors affecting

Potency, drugs receptor role

Potency, interpretations

Potency, loss

Potency, relative, estimation

Potency, stem cells

Potency-based screening

Potency-weighted mean

Pralidoxime reactivation potency

Precision potency

Preclinical trials potency

Prednisolone potency

Prednisone potency

Primary biomolecular target for a homeopathic potency

Product potency

Product potency tests

Protein potency, determination

Purity and Potency

Pyrethroids, insecticidal potency

Quercetin inhibitory potency

Rachitic bone healing potencies of vitamin

Range potency

Rank order of potency

Reactivation potency, acetylcholinesterase

Receptor potency

Reference standard material potency

Relative Potency of Male and Female Plants

Relative Ranking of Potencies

Relative estrogenic potencies

Relative induction potencies

Relative inhibitory potency

Relative potency

Relative potency factor

Relative proliferative potency

Repeatability potency

Reproducibility potency

Revalidation potency

Risk assessment relative potency factor

Robustness potency

Rules for Potency Ligand Efficiency Measures

Selectivity enantiomeric potency

Selectivity potency-based approach

Sensitizing potency

Serotonin-norepinephrine reuptake relative potency

Sexual potency

Sexual potency enhancement

Sieve cut potency

Smoke, toxic potency

Somatostatin analogs potencies

Some Mutagenic Potencies in the Salmonella typhimurium Assay

Specificity potency

Steroidal alkaloids teratogenic potencies

Structural potency

Structure-inhibitory potency relationship

Structure-potency expression

Supply chain potency

Sweeteners, potency

Sweetness potency

System suitability potency

THC potency

Target Potency Energetics of Binding

Target potency

Targeted potency

Teratogenic potencies

Teratogenic potencies of steroidal alkaloids

The Carcinogenic Potency Database

The Carcinogenicity Potency Database

Therapeutic efficacy/potency

Therapeutic efficacy/potency antidepressants

Therapeutic efficacy/potency antipsychotics

Therapeutic efficacy/potency pharmacological

Toxic potency

Toxic potency measurement

Triamcinolone potency

Tricyclic antidepressants potencies

Tryptamines potency

Tumorigenic potency

Vaccine production potency

Validation potency

Verapamil potency

Vitamin biological potency

Vitamin comparative potencies

Vitamin high potency

Vitro Potency and Chemistry Control

© 2024 chempedia.info